Understanding how COVID-19 affects different ancestral groups to find new treatments
Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery
This study is looking at how different genes and environmental factors affect the severity of COVID-19 in hospitalized patients, especially among American Indian and Hispanic communities, to help find better treatments for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of New Mexico Health Scis Ctr NIH-funded |
| Lab location | 1 site (Albuquerque, United States) |
| Project ID | NIH-10661693 on NIH RePORTER |
What this research studies
This research investigates the molecular factors that contribute to the severity and mortality of COVID-19 in hospitalized patients from diverse ancestral backgrounds, particularly focusing on American Indian and Hispanic populations. By analyzing temporal transcriptomics, the study aims to uncover how genetic and environmental factors influence patient outcomes. Participants will be monitored over time to gather data that could lead to the discovery of targeted therapies. The research is conducted at the University of New Mexico Hospital, which serves as a key medical center for these communities.
Who could benefit from this research
Good fit: Ideal candidates for this research include hospitalized COVID-19 patients from American Indian and Hispanic backgrounds, particularly those experiencing severe symptoms.
Not a fit: Patients who are not hospitalized or do not belong to the targeted ancestral groups may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments for COVID-19 that are tailored to the needs of disproportionately affected ancestral groups.
How similar studies have performed: Other research has shown success in understanding disease disparities among different populations, making this approach promising yet still novel in the context of COVID-19.
Where this research is happening
Albuquerque, United States
- University of New Mexico Health Scis Ctr — Albuquerque, United States (Active)
Researchers
- Principal investigator: Perkins, Douglas Jay — University of New Mexico Health Scis Ctr
- Study coordinator: Perkins, Douglas Jay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.